Paolo Calzari

6PUBLICATIONS
53CO-AUTHORS
AllergyEpidemiological methodsAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Jan 21, 2025
Severe Allergic Contact Dermatitis to Hair Dye in a Patient With Atopic Dermatitis During Dupilumab Therapy.

Alessandra Chiei Gallo, Gianluca Tavoletti, Gianluca Avallone

|Jun 28, 2024
Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres.

Gianluca Tavoletti, Alessandra Chiei-Gallo, Luigi Gargiulo

|Apr 28, 2023
Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?

Riccardo Asero, Silvia Mariel Ferrucci, Paolo Calzari

|Jan 21, 2023
Uses of Polypodium leucotomos Extract in Oncodermatology.

Paolo Calzari, Silvia Vaienti, Gianluca Nazzaro

Pageof 1

Frequent Collaborators

5 joint publications

Silvia Mariel Ferrucci

4 joint publications

Angelo Valerio Marzano

4 joint publications

Gianluca Avallone

4 joint publications

Francesca Barei